Key result
Intracoronary injection of autologous blood successfully managed slow-flow and no-reflow phenomenon during primary percutaneous coronary intervention for acute coronary syndrome.
Why the study?
Slow-flow and no-reflow cause sudden loss of coronary artery flow typically after stenting or angioplasty in primary PCI, prompting alternative techniques beyond conventional therapy.
Does autologous blood injection into the intracoronary artery improve slow-flow and no-reflow in acute coronary syndrome related to primary PCI?
Does autologous blood injection into the intracoronary artery improve slow-flow and no-reflow in acute coronary syndrome related to primary PCI?
Intracoronary injection of autologous blood may serve as an alternative technique to manage no-reflow phenomenon during primary PCI.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for autologous blood in no-reflow during primary PCI; prospective trials needed before clinical adoption.
Slow flow and no-reflow phenomenon are taken to sudden loss of coronary artery flow, typically after stenting or angioplasty in primary PCI. Otherwise conventional therapy, we report a technique, which autologous blood into intracoronary to supply oxygen and break process thrombosis results in successfully management no-reflow in primary PCI
No takes yet. Share an insight, caveat, or question.
Hoai et al. (2021) studied this question. Intracoronary injection of autologous blood successfully managed slow-flow and no-reflow phenomenon during primary percutaneous coronary intervention for acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: